Vinay K. Venishetty
Hyderabad, TG, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Physiologically based pharmacokinetic modelling to predict artemether and lumefantrine exposure in neonates weighing less than 5 kg treated with artemether-lumefantrine to supplement the clinical data from the CALINA study.
Journal: Tropical medicine and health
Published: May 12, 2025
Pharmacokinetics, safety and efficacy of an optimized dose of artemether-lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in neonates and infants of less than 5 kg body weight: a multicentre, open-label, single-arm phase 2/3 study (CALINA).
Journal: Tropical medicine and health
Published: May 12, 2025
Importance of tailored non-clinical safety testing of novel antimalarial drugs: Industry best-practice.
Journal: Regulatory toxicology and pharmacology : RTP
Published: August 09, 2024
First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adults.
Journal: Antimicrobial agents and chemotherapy
Published: July 26, 2024
Effects of triclabendazole and its metabolite exposure on the heart-rate-corrected QT intervals: A randomized, placebo- and positive-controlled thorough QT study in healthy individuals.
Journal: Clinical and translational science
Published: April 09, 2023
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 06, 2021
Triclabendazole in the treatment of human fascioliasis: a review.
Journal: Transactions of the Royal Society of Tropical Medicine and Hygiene
Published: May 27, 2019
A First-in-Human Study To Assess the Safety and Pharmacokinetics of LYS228, a Novel Intravenous Monobactam Antibiotic in Healthy Volunteers.
Journal: Antimicrobial agents and chemotherapy
Published: December 12, 2018
Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer.
Journal: Current cancer drug targets
Published: June 15, 2016
Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: November 09, 2011
β-Hydroxybutyric acid grafted solid lipid nanoparticles: a novel strategy to improve drug delivery to brain.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: August 31, 2011
Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Journal: Colloids and surfaces. B, Biointerfaces
Published: August 31, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026